Emilia Bialopiotrowicz, PhD^1*, Monika Noyszewska-Kania, MSc^2*, Ewa Jabłońska, PhD^2*, Tomasz Sewastianik, PhD^1*, Monika Stańczak, Msc^3*, Anna Szumera-Ciećkiewicz, MD, PhD^3*, Katarzyna Borg, PhD^3*, Aleksandra Bluszcz, Msc^3*, Sonia Dębek, MSc^1*, Monika Prochorec-Sobieszek, MD, PhD^3*, Anna Polak, PhD^1*, Patryk Górniak, PhD^1*, Maciej Szydlowski, PhD^1* and Przemyslaw Juszczynski, MD, PhD^1*

¹Department of Experimental Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland
²Department of Experimental Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, POL
³Department of Diagnostic Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland

Mark Yan^1*, Yi Meng Chang^1*, Vibha Raghavan^1*, Estella Dong^1*, Christian Klein, PhD², Tina G Nielsen^2*, Joseph N Paulson^3* and Katerina Hatzi^3*

¹F. Hoffmann-La Roche Ltd, Mississauga, ON, Canada
²F. Hoffmann-La Roche Ltd, Basel, Switzerland
³Genentech, Inc., South San Francisco, CA

Maciej Szydlowski, PhD^1*, Michał Pawlak, PhD^1*, Filip Garbicz, MD^1,2*, Patryk Górniak, PhD^1*, Justyna Żurańska, PhD^3*, Magdalena Król, PhD^4*, Bartłomiej Taciak^4*, Maciej Białasek^4*, Anna Szumera-Ciećkiewicz, MD, PhD^5*, Kamil Sokół^5*, Monika Stańczak, Msc^5*, Daria Owczarek^5*, Monika Prochorec-Sobieszek, MD, PhD^5*, Anna Polak, PhD^1*, Emilia Bialopiotrowicz, PhD^1*, Michał Kurlapski^6*, Jan Zaucha, MD PhD^6*, Paweł Wołkow, PhD^3* and Przemyslaw Juszczynski, MD, PhD^1*

¹Department of Experimental Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland
²Postgraduate School of Molecular Medicine, Medical University of Warsaw, Warsaw, Poland
³Center for Medical Genomics OMICRON, Jagiellonian University Medical College, Cracow, Poland
⁴Faculty of Veterinary Medicine, Warsaw University of Life Sciences, Warsaw, Poland
⁵Department of Diagnostic Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland
⁶Department of Hematology and Transplantology, Medical University of Gdansk, Gdansk, Poland

Catherine Thieblemont, MD, PhD¹, Loïc Chartier^2*, Ulrich Dührsen, Prof, MD, PhD^3*, Umberto Vitolo, MD⁴, Sally F Barrington, Prof, MD, PhD^5*, Laetitia Vercellino^6*, Jan Zaucha, MD PhD^7*, Inês Patrocinio Carvalho^8*, Gomes da Silva Maria, MD, PhD^9*, Pierre Decazes^10*, Pierre-Julien Viailly^11*, Herve Tilly, MD, PhD¹⁰, Alina Berriolo-Riedinger^12*, Rene-Olivier Casasnovas, MD^13*, Andreas Hüttmann, MD¹⁴, Hajira Ilyas^15*, George Mikhaeel, Prof, MD, PhD^16*, Joel Dunn^17*, Anne Ségolène Cottereau, MD^18*, Christine Schmitz, MD^19*, Joseph N. Paulson^20*, Tina G Nielsen^21* and Michel Meignan, MD^22*

¹Hôpital Saint-Louis, Paris, France
²Centre Hospitalier Lyon-Sud, LYSARC, PIERRE-BÉNITE Cedex, France
³University Hospital Essen, Essen, Germany
⁴Candiolo Cancer Institute, FPO-IRCCS, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Torino, Italy
⁵Guy's and St. Thomas' Hospital and Kings College, London, Kent, United Kingdom
⁶Hôpital Saint Louis, Paris, France
⁷Department of Hematology and Transplantology, Medical University of Gdansk, Gdansk, Poland
⁸IPO (Institute of Oncology Francisco Gentil), Lisboa, Portugal
⁹Instituto Português de Oncologia - Centro de Lisboa, Departamento de Hematologia, Lisboa, Portugal
¹⁰Centre Henri Becquerel, Rouen, France
¹¹INSERM U1245, Centre Henri Becquerel, UNIROUEN, University of Normandie, Rouen, France
¹²CGFL, Dijon, France
¹³Hématologie Clinique and INSERM 1231, CHU Dijon, Dijon, France
¹⁴Department of Hematology, University Hospital, Essen, NRW, Germany
¹⁵King's College London and Guy's and St Thomas' NHS Foundation Trust, London, United Arab Emirates
¹⁶Department of Clinical Oncology, Guy’s and St Thomas’ NHS Foundation Trust and Cancer Division, Kings College London, London, United Kingdom
¹⁷King's College London, London, United Kingdom
¹⁸Nuclear Medicine, APHP Cochin Hospital, PARIS, France
¹⁹Department of Hematology, Universitatsklinikum Essen, Essen, Germany
²⁰Genentech, Inc., South San Francisco, CA
²¹F. Hoffmann-La Roche Ltd, Basel, Switzerland
²²LYSA, Paris, France

Tomohiro Aoki, MD, PhD^1,2*, Lauren C. Chong, MSc^1*, Katsuyoshi Takata, MD, PhD^1*, Katy Milne^3*, Elizabeth Chavez, BSc, Cg RT^1*, Tomoko Miyata-Takata, MD, PhD^1*, Susana Ben-Neriah, BSc^4*, Doria Unrau^5*, Adele Telenius^1*, Merrill Boyle, BSc^1*, Pedro Farinha, MD, PhD¹, Andrew P. Weng, MD⁶, Kerry J. Savage, MD MSc⁷, David W. Scott, MBChB, PhD⁸, Sohrab P Shah^9,10*, Brad H. Nelson^3,11* and Christian Steidl, MD^1,2

¹Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
²Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada
³Deeley Research Centre, BC Cancer, Vancouver, BC, Canada
⁴Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada
⁵DeeleyResearch Centre, BC Cancer, Vancouver, BC, Canada
⁶Terry Fox Laboratory, BC Cancer, Vancouver, BC, Canada
⁷BC Cancer Centre for Lymphoid Cancer, University of British Columbia and the Department of Medical Oncology, Vancouver, BC, Canada
⁸BC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Vancouver, BC, Canada
⁹Department of Molecular Oncology, BC Cancer, Vancouver, BC, Canada
¹⁰Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
¹¹Department of Biochemistry and Microbiology, University of Victoria, Victoria, BC, Canada

Rachel Koldej, PhD^1,2*, Ashvind Anand Prabahran, MBBS, FRACP, FRCPA^1,3* and David Ritchie, MB ChB, PhD, FRACP, FRCPA^4,5,6

¹ACRF Translational Research Laboratory, Royal Melbourne Hospital, Melbourne, Australia
²Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, Australia
³Department of Clinical Haematology and Bone Marrow Transplant Service, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, Australia
⁴Department of Clinical Haematology and Bone Marrow Transplant Service, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC, Australia
⁵ACRF Translational Research Laboratory, The Royal Melbourne Hospital, Melbourne, VIC, Australia
⁶The University of Melbourne, Parkville, VIC, Australia

Edward Truelove, MBBS, BSc, MRCP, FRCPath^1*, Joseph G Taylor, MBBS, BSc^2*, Andrew James Clear, BSc^3*, Mariarita Calaminici^3* and Professor John G. Gribben, MD, DSc⁴

¹Centre for Haemato-oncology, Barts Cancer Institute, Queen Mary University of London, London, ENG, United Kingdom
²Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, ENG, United Kingdom
³Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom
⁴Barts Cancer Institute, Queen Mary University of London, London, United Kingdom